000 | 01107 a2200325 4500 | ||
---|---|---|---|
005 | 20250513142010.0 | ||
264 | 0 | _c19980521 | |
008 | 199805s 0 0 eng d | ||
022 | _a0048-5764 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWigal, S B | |
245 | 0 | 0 |
_aReliability and validity of the SKAMP rating scale in a laboratory school setting. _h[electronic resource] |
260 |
_bPsychopharmacology bulletin _c1998 |
||
300 |
_a47-53 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDopamine Uptake Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethylphenidate _xtherapeutic use |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 | _aReproducibility of Results |
700 | 1 | _aGupta, S | |
700 | 1 | _aGuinta, D | |
700 | 1 | _aSwanson, J M | |
773 | 0 |
_tPsychopharmacology bulletin _gvol. 34 _gno. 1 _gp. 47-53 |
|
999 |
_c9531269 _d9531269 |